Clinical Trial Update: Thalidomide Low Threshold in Epilepsy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating thalidomide for refractory epilepsy has completed, with results posted in 2010. The study was sponsored by a Mexican nationa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Institute of Neurology and Neurosurgery, Mexico | Conditions: Refractory Epilepsy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-02-03